Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing's syndrome

Journal of Bone and Mineral Research

Volumn 24, Issue 11, 2009, Pages 1841-1846

  Barahona, Maria José ^a   Sucunza, Nuria ^a   Resmini, Eugenia ^a   Fernández Real, Jose Manuel ^b   Ricart, Wifredo ^b   Moreno Navarrete, Jose Maria ^b   Puig, Teresa ^a   Wägner, Ana M ^a   Rodriguez Espinosa, José ^a   Farrerons, Jordi ^a   Webb, Susan M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

BMD; Bone mass; Cushing's syndrome; Glucocorticoid replacement; Osteocalcin

Indexed keywords

ESTROGEN; GLUCOCORTICOID; OSTEOCALCIN;

ADRENALECTOMY; ADULT; ARTICLE; BODY MASS; BONE DENSITOMETRY; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN DEFICIENCY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERCORTISOLISM; LUMBAR SPINE; REMISSION; TREATMENT DURATION; BONE; CASE CONTROL STUDY; CUSHING SYNDROME; DRUG EFFECT; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; REGRESSION ANALYSIS; TIME;

ADULT; BONE AND BONES; CASE-CONTROL STUDIES; CUSHING SYNDROME; FEMALE; GLUCOCORTICOIDS; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; ORGAN SIZE; REGRESSION ANALYSIS; REMISSION INDUCTION; TIME FACTORS;

EID: 73949142866     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090505     Document Type: Article

References (31)

1. Canalis E, Giustina A 2001 Glucocorticoid-induced osteoporosis: Summary of a workshop. J Clin Endocrinol Metab 86: 5681-5685.
2. Chiodini I, Torlontano M, Carnevale V, Trischitta V, Scillitani A 2008 Skeletal involvement in adult patients with endogenous hypercortisolism. J Endocrinol Invest 31:267-276.
3. Mancini T, Doga M, Mazziotti G, Giustina A 2004 Cushing's syndrome and bone. Pituitary 7:243-246.
4. Shaker JL, Lukert BP 2005 Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin North Am 34:341-356.
5. Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J 2006 Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: A prospective, long-term study. Eur J Endocrinol 154:109-118.
6. Manning PJ, Evans MC, Rei IR 1992 Normal bone mineral density following cure of Cushing's syndrome. Clin Endocrinol (Oxf) 36:229-234.
7. Vestergaard P, Lindholm J, Jorgensen JOL, Hagen C, Hoeck HC, Laurberg P, Rejnmark L, Brixen K, Kristensen L, Feldt-Rasmussen U, Mosekilde L 2002 Increased risk of osteoporotic fractures in patients with Cushing's syndrome. Eur J Endocrinol 146:51-56.
8. Di Somma C, Pivonello R, Loche S, Faggiano A, Klain M, Salvatore M, Lombardi G, Colao A 2003 Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adults patients with Cushing's disease: A prospective study. Clin Endocrinol (Oxf) 58:302-308.
9. Hermus AD, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW 1995 Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab 80:2859-2865.
10. Faggiano A, Pivonello R, Filippella M, Di Somma C, Orio F, Lombardi G, Colao A 2001 Spine abnormalities and damage in patients cured from Cushing's disease. Pituitary 4:153-161.
11. Arlt W, Rosenthal C, Hahner S, Allolio B 2006 Quality of glucocorticoid replacement in adrenal insufficiency: Clinical assessment vs timed serum cortisol measurements. Clin Endocrinol (Oxf) 64:384-389.
12. King JA, Wisniewski AB, Bankowski BJ, Carson KA, Zacur HA, Migeon CJ 2006 Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 91:865-869.
13. Sciannamblo M, Russo G, Cuccato D, Chiumello G, Mora S 2006 Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab 91:4453-4458.
14. Crown A, Lightman S 2005 Why is the management of glucocorticoid deficiency still controversial: A review of the literature. Clin Endocrinol (Oxf) 63:483-492.
15. Lukert BP 2006 Editorial: Glucocorticoid replacement - How much is enough?. J Clin Endocrinol Metab 91:793-794.
16. Mosteller RD 1987 Simplified calculation of body-surface area. N Engl J Med 317:1098.
17. Webb SM, Rigla M, Wägner AM, Oliver B, Bartumeus F 1999 Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J Clin Endocrinol Metab 84:3696-3700.
18. Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C 2000 Oral corticosteroids and fracture risk: Relationship to daily and cumulative doses. Rheumatology 39:1383-1389.
19. Tauchmanovà L, Pivonello R, Di Somma C, Rossi R, De Martino MC, Camera L, Klain M, Salvatore M, Lombardi G, Colao A 2006 Bone demineralization and vertebral fractures in endogenous cortisol excess: Role of disease etiology and gonadal status. J Clin Endocrinol Metab 91:1779-1784.
20. Minetto M, Reimondo G, Osella G, Ventura M, Angeli A, Terzolo M 2004 Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome. Osteoporos Int 15:855-861.
21. Ohmori N, Nomura K, Ohmori K, Kato Y, Itoh T, Takano K 2003 Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome. Endocr J 50:1-7.
22. Karavitaki N, Ioannidis G, Giannakopoulos F, Mavrokefalos P, Thalassinos N 2004 Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome. Clin Endocrinol (Oxf) 60:264-270.
23. Chiodini I, Carnevale V, Torlontano M, Fusilli S, Guglielmi G, Pileri M, Modoni S, Di Giorgio A, Liuzzi A, Minisola S, Cammisa M, Trischitta V, Scillitani A 1998 Alterations of bone turnover and mass at different skeletat sites due to pure glucocorticoid excess: Study in eumenorrheic patients with Cushing's syndrome. J Clin Endocrinol Metab 83:1863-1867.
24. Barahona MJ, Sojo L, Wägner AM, Bartumeus F, Oliver B, Cano P, Webb SM 2005 Determinants of neurosurgical outcome in pituitary tumors. J Endocrinol Invest 28:787-794.
25. Piovesan A, Terzolo M, Reimondo G, Pia A, Codegone A, Osella G, Boccuzzi A, Paccotti P, Angeli A 1994 Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. Horm Metab Res 26:234-237.
26. Sartorio A, Ambrosi B, Colombo P, Morabito F, Faglia G 1988 Osteocalcin levels in Cushing's disease before and after treatment. Horm Metab Res 20:70.
27. Stewart PM 2003 Tissue-specific Cushing's syndrome, 11β- hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action. Eur J Endocrinol 149:163-168.
28. Cooper MS, Rabbitt EH, Goddard PE, Bartlett WA, Hewison M, Stewart PM 2002 Osteoblastic 11beta-hydroysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. J Bone Miner Res 17:979-986.
29. Osella G, Terzolo M, Reimondo G, Piovesan A, Pia A, Termine A, Paccotti P, Angeli A 1997 Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas. J Clin Endocrinol Metab 82:3303-3307.
30. Godang K, Ueland T, Bollerslev J 1999 Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing's syndrome. Eur J Endocrinol 141:126-131.
31. Di Somma C, Colao A, Pivonello R, Klain M, Faggiano A, Tripodi FS, Merola B, Salvatore M, Lombardi G 1998 Efectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease. Clin Endocrinol (Oxf) 48:655-662.